Welcome to our dedicated page for Materialise SEC filings (Ticker: MTLS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Materialise NV files as a foreign private issuer, and its SEC reports document financial results, capital actions, and corporate disclosures for its additive manufacturing software, medical, and manufacturing businesses. Form 6-K reports include quarterly result releases, segment revenue for Materialise Medical, Materialise Software, and Materialise Manufacturing, expense categories such as R&D, sales and marketing, and general and administrative costs, cash balances, and exhibits incorporated by reference into a Form F-3 registration statement.
The company’s filings also cover Belgian-law annual report materials, share buyback program updates, treasury-share holdings, exchange execution details, and share-capital disclosures tied to its Nasdaq ADSs and Euronext-listed ordinary shares.
Materialise NV reports progress on its ongoing share buy-back program of up to EUR 30 million. Between 13 and 17 April 2026, the company repurchased 31,054 shares at an average price of EUR 4.45, for a total of EUR 138,089, via Nasdaq.
Since the program began on 26 January 2026, Materialise has bought back 576,583 shares for EUR 2,593,856 (USD 3,055,313), equal to about 1% of total shares outstanding. All repurchases were executed through the central order book, with no cross or block trades.
Materialise NV reports progress on its previously announced share buy-back program of up to EUR 30 million. Between 6 and 10 April 2026, the company repurchased 24,690 shares at an average price of 4.32 EUR, for a total of 106,768 EUR (124,267 USD).
Since the program began on 26 January 2026, Materialise has bought back 545,529 shares for 2,455,767 EUR (2,893,063 USD), representing 0.9% of its total shares outstanding, which it now holds as treasury shares.
Materialise NV reports progress on its ongoing share buyback program. Between 30 March 2026 and 3 April 2026, the company repurchased 21,361 shares at an average price of 4.29 EUR, for a total of 91,712 EUR, via Nasdaq.
Under the program, Materialise can buy back up to EUR 30 million of its shares through an independent financial intermediary. Since the program began on 26 January 2026, it has repurchased 520,839 shares for 2,349,000 EUR (2,768,796 USD), equal to 0.9% of total shares outstanding, which it now holds as treasury shares.
Materialise NV reports progress on its ongoing share buy-back program of up to EUR 30 million. During the week from 23 to 27 March 2026, the company repurchased 50,994 shares at an average price of 4.26 EUR per share, for a total of 217,478 EUR.
All purchases were executed on Nasdaq through the central order book, with no cross or block trades. Since the program started on 26 January 2026, Materialise has bought back 499,478 shares for 2,257,288 EUR (2,663,137 USD), equal to 0.8% of its total shares outstanding, and now holds these shares in treasury.
Materialise NV reports further progress on its share buy-back program of up to EUR 30 million. Between 16 and 20 March 2026, the company repurchased 46,665 shares at an average price of 4.39 EUR, for a total of 204,627 EUR.
Since the program began on 26 January 2026, Materialise has bought back 448,484 shares for 2,039,810 EUR (approximately 2,411,424 USD), representing about 0.8% of total shares outstanding. Materialise now holds 448,484 of its own shares.
Materialise NV reports progress on its ongoing share buyback program of up to EUR 30 million. Between 9 and 13 March 2026, the company repurchased 52,701 shares on Nasdaq at an average price of EUR 4.62, for a total of EUR 243,690 (USD 281,523). Since the program began on 26 January 2026, Materialise has bought back 401,819 shares for EUR 1,835,183 (USD 2,175,722), equal to 0.7% of total shares outstanding, which it now holds as treasury shares.
Materialise NV reports progress on its previously announced share buy-back program of up to EUR 30 million. From 2 March 2026 through 6 March 2026, the company repurchased 36,121 shares at an average price of EUR 4.49, for a total of EUR 162,264.
Since the start of the program on 26 January 2026, Materialise has bought back 349,118 shares for EUR 1,591,493 (USD 1,894,199), representing 0.6% of total shares outstanding. Materialise now holds these 349,118 shares in treasury.
Materialise NV reports progress on its previously announced share buy-back program of up to EUR 30 million. During the week from 23 to 27 February 2026, the company repurchased 79,791 shares at an average price of 4.30 EUR, for a total of 342,715 EUR.
Since the program began on 26 January 2026, Materialise has bought back 312,997 shares for 1,429,229 EUR (approximately 1,705,609 USD), representing about 0.5% of its total shares outstanding, which the company now holds as treasury shares.
Materialise NV reports progress on its previously announced share buy-back program of up to EUR 30 million. Between 16 and 20 February 2026, the company repurchased 69,861 shares at an average price of 4.76 EUR per share, for a total of 332,435 EUR.
All purchases during this week were executed on NASDAQ and no shares were bought via cross or block trades. Since the program started on 26 January 2026, Materialise has bought back 233,206 shares for 1,086,514 EUR (1,286,818 USD), equal to 0.4% of total shares outstanding.
Materialise NV reported stronger fourth-quarter 2025 results, with revenue up 6.8% to 70,164 kEUR and net profit rising to 6,206 kEUR from 2,907 kEUR. Gross margin improved to 58.1%, while operating profit swung to 3,111 kEUR from a loss a year earlier.
Growth was driven by the Materialise Medical segment, whose Q4 revenue rose 16.3% and Adjusted EBITDA margin reached 35.2%. For full year 2025, revenue was broadly stable at 267,633 kEUR, but net profit declined to 7,716 kEUR from 13,406 kEUR, mainly due to weaker financial result and foreign exchange impacts. Cash and cash equivalents increased to 133,918 kEUR, and Adjusted EBITDA margin improved slightly to 12.1%.